Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pain × Hydromorphone × Clear all

Phase

Phase 3 5 Phase 4 3 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Methadone 2 Cryotherapy 2 Cryosurgery 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 piperine 1 Sodium Bicarbonate 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Propofol 1 Photochemotherapy 1 Morphine 1 Lidocaine 1 Laser Therapy 1 Hydromorphone 1 Electroencephalography 1 Dronabinol 1 Dexamethasone 1 Curcumin 1 Calcium Dobesilate 1 Acupuncture Therapy 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01824524 2014-08-15

A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer

Xian-Janssen Pharmaceutical Ltd.

Phase 1 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡